20 min

Ep. 8: Engaging FDA & Accelerating Innovation w. Dr. Carlos Peña Journey into the Future of Medicine with Bill Maggio

    • Medicine

Carlos Peña, PhD, MS, is Chief Regulatory Officer, leading the newly established Office of Regulatory Services at the Jacobs Institute. Prior to the JI, Carlos served as the Director of the Office of Neurological and Physical Medicine Devices, at the Center for Devices and Radiological Health (CDRH), at the U.S. Food and Drug Administration (FDA). He was also the Assistant Director of Emerging Technologies in the Executive Office of President Barack Obama (2012-2014). He joins us to discuss the FDA's medical device approval process, how the JI's newly established Office of Regulatory Affairs will benefit the Buffalo-Niagara region, and more. 
 
'Can the FDA Keep Up?' is the chapter in the Jacobs Institute’s Future of Medicine report that challenges whether the agency can keep pace with medical innovation.
 
Visit our Future of Medicine web page.
Learn more about the Jacobs Institute.
To help further the future of medicine, please consider supporting us today.

Carlos Peña, PhD, MS, is Chief Regulatory Officer, leading the newly established Office of Regulatory Services at the Jacobs Institute. Prior to the JI, Carlos served as the Director of the Office of Neurological and Physical Medicine Devices, at the Center for Devices and Radiological Health (CDRH), at the U.S. Food and Drug Administration (FDA). He was also the Assistant Director of Emerging Technologies in the Executive Office of President Barack Obama (2012-2014). He joins us to discuss the FDA's medical device approval process, how the JI's newly established Office of Regulatory Affairs will benefit the Buffalo-Niagara region, and more. 
 
'Can the FDA Keep Up?' is the chapter in the Jacobs Institute’s Future of Medicine report that challenges whether the agency can keep pace with medical innovation.
 
Visit our Future of Medicine web page.
Learn more about the Jacobs Institute.
To help further the future of medicine, please consider supporting us today.

20 min